Browse All

Current Filters

CLEAR FILTER x

TITLE

ENABLE: The First Phase 4 Observational Study for Patients with Relapsing MS Treated with Ublituximab in Real World Clinical Setting

Author:Fox, Edward   Parker, Jackie   Bodhinathan, Karthik   Sportelli, Peter   Miskin, Hari   Hersh, Carrie   

Session Name:P7: Multiple Sclerosis: Disease-modifying Therapies: Real-world Evidence and Adverse Events 1  

Topic:Multiple Sclerosis  

Program Number:P7.014  

Author Institution:TG Therapeutics, Round Rock, TX  TG Therapeutics, Morrisville, NC  TG Therapeutics, Lexington, MA  TG Therapeutics, New York, NY  Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV  

Retrospective Evaluation of Infusion Tolerability: Ublituximab Real-world Observational Survey (ENAMOR)

Author:Fox, Edward   Sportelli, Peter   Miskin, Hari   Garner, Chris   

Session Name:P7: Multiple Sclerosis: Disease-modifying Therapies: Real-world Evidence and Adverse Events 1  

Topic:Multiple Sclerosis  

Program Number:P7.015  

Author Institution:TG Therapeutics, Round Rock, TX  TG Therapeutics, Stuart, FL  TG Therapeutics, New York, NY  TG Therapeutics, Ozark, MO